{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01274975",
      "OrgStudyIdInfo": {
        "OrgStudyId": "Astrostem"
      },
      "Organization": {
        "OrgFullName": "R-Bio",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury.",
      "OfficialTitle": "Safety of Autologous Adipose Derived Mesenchymal Stem Cells in Patients With Spinal Cord Injury",
      "Acronym": "MSC"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2014",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "July 2009"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "November 2009",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "February 2010",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "January 6, 2011",
      "StudyFirstSubmitQCDate": "January 11, 2011",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "January 12, 2011",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "March 24, 2014",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 26, 2014",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "R-Bio",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {},
    "DescriptionModule": {
      "BriefSummary": "This study is designed to assess the safety of intravenous autologous adipose derived mesenchymal stem cells transplant in spinal cord injury patients.",
      "DetailedDescription": "Adipose derived mesenchymal stem cells (AdMSCs) represent an attractive and ethical cell source for stem cell therapy.\n\nWith the recent demonstration of MSC homing properties, intravenous aplications of MSCs to cell-damaged diseases have increased.\n\nIn a human clinical trial, eight male patients who had suffered a spinal cord injury were intravenously administered autologous hAdMSCs (4×10e8 cells) one time."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Spinal Cord Injury"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "8",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Other",
            "InterventionName": "Autologous Adipose Derived Mesenchymal Stem Cells",
            "InterventionDescription": "Intravenous infusion of Autologous Adipose Derived Mesenchymal Stem Cells. Dose : 4 x 10e8 cells",
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Astrostem®"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "safety evaluation",
            "PrimaryOutcomeDescription": "Safety evaluate through physical examination, vital sign and laboratory test after \"RNL-Astrostem\" injected",
            "PrimaryOutcomeTimeFrame": "12weeks"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSubjects who understand and sign the consent form for this study.\nAge :19-60, males\nClinical diagnosis of spinal cord injury(American Spinal Injury Association[ASIA] Impairment Scale[AIS] grade A or B or C)\nDuration of injury : > 2 months\n\nExclusion Criteria:\n\nSubjects who must put on a respirator\nSubjects who had malignant tumor within 5 years\nSubjects with a infectious disease include HIV and hepatitis\nSubjects who injured brain or spinal cord before spinal cord injury\nSubjects who has high body temperature more than 38℃ or acute disorder\nSubjects with anemia or thrombocytopenia\nSubjects with angina pectoris, myocardial infarction, cardiomyopathy, occlusive disease, chronic renal failure, glomerular disease and chronic obstructive pulmonary disease\nSubjects with congenital or acquired immunodeficiency disorders\nSubjects with muscular dystrophy or articular rigidity\nPatients with clouded consciousness or speech disorder\ntreat with cytotoxic medications(immunosuppressive drug, corticosteroid and cytotoxic drug) during clinical trials\nparticipating another clinical trials within 3 months\nother serious disease or disorder that could seriously affect ability to participate in the study",
      "HealthyVolunteers": "No",
      "Gender": "Male",
      "MinimumAge": "19 Years",
      "MaximumAge": "60 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "SangHan Kim, MD",
            "OverallOfficialAffiliation": "Anyang Sam Hospital",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "21303266",
            "ReferenceType": "result",
            "ReferenceCitation": "Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, Lee HY, Kim YJ, Jo JY, Yoon EJ, Choi HJ, Kwon E. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 2011 Aug;20(8):1297-308. doi: 10.1089/scd.2010.0466. Epub 2011 Mar 17."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000013119",
            "ConditionMeshTerm": "Spinal Cord Injuries"
          },
          {
            "ConditionMeshId": "D000014947",
            "ConditionMeshTerm": "Wounds and Injuries"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000013118",
            "ConditionAncestorTerm": "Spinal Cord Diseases"
          },
          {
            "ConditionAncestorId": "D000002493",
            "ConditionAncestorTerm": "Central Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000009422",
            "ConditionAncestorTerm": "Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000020196",
            "ConditionAncestorTerm": "Trauma, Nervous System"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M15068",
            "ConditionBrowseLeafName": "Spinal Cord Injuries",
            "ConditionBrowseLeafAsFound": "Spinal Cord Injury",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M16837",
            "ConditionBrowseLeafName": "Wounds and Injuries",
            "ConditionBrowseLeafAsFound": "Injury",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M15067",
            "ConditionBrowseLeafName": "Spinal Cord Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4894",
            "ConditionBrowseLeafName": "Central Nervous System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M21176",
            "ConditionBrowseLeafName": "Trauma, Nervous System",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC26",
            "ConditionBrowseBranchName": "Wounds and Injuries"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}